Showing results (91-100 of 140) with videos related to
Sort By:
Pageof 14
Journal of Clinical Medicine|September 9, 2023
Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 VariantRobert Flisiak, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 1, 2015
Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter studyDonald M Jensen, Michael Brunda, Robert Elston, et al.Journal of Viral Hepatitis|August 7, 2024
Sustained Virological Response After Early Discontinuation of Hepatitis C TreatmentRobert Flisiak, Dorota Zarębska-Michaluk, Ewa Janczewska, et al.Expert Review of Anti-Infective Therapy|May 9, 2024
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patientsAnna Piekarska, Aleksandra Berkan-Kawińska, Hanna Berak, et al.Vaccine|July 2, 2025
Tracking clinical severity of influenza in adult hospitalized patients in 2024: Data from the FluTer registry in PolandPiotr Rzymski, Robert Pleśniak, Anna Piekarska, et al.Journal of Clinical Medicine|January 21, 2022
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV CoinfectionDorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, et al.International Journal of Occupational Medicine and Environmental Health|August 24, 2017
Poisoning deaths in Poland: Types and frequencies reported in Łódź, Kraków, Sosnowiec, Gdańsk, Wrocław and Poznań during 2009-2013Anna Krakowiak, Anna Piekarska-Wijatkowska, Katarzyna Kobza-Sindlewska, et al.Clinical and Experimental Hepatology|October 4, 2023
Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antiviralsRobert Flisiak, Dorota Zarębska-Michaluk, Hanna Berak, et al.Pharmacological Reports : PR|April 23, 2025
Unraveling Poland's unprecedented influenza surge in early 2025: increased viral severity or post-pandemic vulnerability?Piotr Rzymski, Anna Piekarska, Robert Pleśniak, et al.Scientific Reports|July 1, 2025
Response to therapy with direct antiviral drugs in HCV-infected patients with diabetesMichał Brzdęk, Dorota Zarębska-Michaluk, Piotr Rzymski, et al.Pageof 14